Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tony Nguyen

Sports Medicine Phoenix, AZ Medical Doctor

NPI 1598939175 CMS profile 835779

18444 N 25Th Ave, Ste 210, Phoenix, AZ 85023

Open in the dashboard

General payments

$37,892

140 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tony Nguyen of Phoenix, AZ is reported in the CMS Open Payments database as having received $37,892 across 140 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $642 9
2024 General $3,055 10
2023 General $2,985 33
2022 General $13,172 47
2021 General $12,824 28
2020 General $1,465 6
2019 General $3,749 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tony Nguyen
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Tony Nguyen were reported at $642. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Tony Nguyen Sports Medicine median Middle half National median
2019 $3,749 $1,176 $199–$4,249 $163
2020 $1,465 $708 $96–$2,890 $114
2021 $12,824 $1,213 $152–$3,994 $132
2022 $13,172 $1,230 $159–$3,998 $149
2023 $2,985 $584 $146–$2,836 $160
2024 $3,055 $628 $163–$3,168 $164
2025 $642 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $19,711 24 payments
  2. DePuy Synthes Products, Inc. $5,683 5 payments
  3. Arthrex, Inc. $5,673 31 payments
  4. ImpactOrtho, Inc. $3,343 24 payments
  5. DePuy Synthes Sales Inc. $1,254 23 payments
  6. Stryker Corporation $1,183 15 payments
  7. Integra LifeSciences Corporation $327 2 payments
  8. Smith+Nephew, Inc. $267 2 payments
  9. Vericel Corporation $247 8 payments
  10. Zimmer Biomet Holdings, Inc. $65 1 payment
  11. Other $137 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $23,103 7 payments
  2. Food and Beverage $7,086 109 payments
  3. Travel and Lodging $3,826 21 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,500 1 payment
  5. Education $1,200 1 payment
  6. Long term medical supply or device loan $177 1 payment
Products named General payments · program years 2019–2025
  1. RIGIDLOOP Sports Surgical $19,647 16 payments
  2. COR Sports Surgical $19,133 10 payments
  3. Omnispan Orthocord $19,133 10 payments
  4. BIOINTRAFIX Sports Surgical $19,133 10 payments
  5. ARTHROSCOPE SHEATH $3,192 2 payments
  6. COR Sports Surgical $1,185 1 payment
  7. OMNISPAN $1,185 1 payment
  8. RIGIDLOOP Sports Surgical $1,185 1 payment
  9. BIOINTRAFIX Sports Surgical $1,185 1 payment
  10. FMS $545 10 payments
  11. Other $4,938 68 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$36,790

Of which drugs: $741

Medicare patients

103

Average age 71

Services billed

656

55 women, 48 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 74%
High blood pressure 61%
Diabetes 30%
Ischemic heart disease 25%
Depression 21%
Osteoporosis 17%
Atrial fibrillation 15%
Chronic kidney disease 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 39 228 $172

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Lenvima
  • Eisai Inc. $21
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

140 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record